Search research articles
Contact Us
Filters
Showing results (81-90 of 117) with videos related to
Page
of 12
Sort By:
British Journal of Haematology
|
March 29, 2026
Hepatitis C virus and hepatitis B virus in indolent lymphomas: Prospective data from the international observational NF10 study
Luca Arcaini, Michele Merli, Sara Rattotti, et al.
Blood Cancer Journal
|
October 7, 2018
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project
Daniela Barraco, Barbara Mora, Paola Guglielmelli, et al.
Hematological Oncology
|
September 30, 2022
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi
Emanuele Cencini, Alessandra Tucci, Benedetta Puccini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2019
DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma
Ian W Flinn, Carole B Miller, Kirit M Ardeshna, et al.
Leukemia
|
December 15, 2019
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Marco Frigeni, Caroline Besson, Carlo Visco, et al.
Hemasphere
|
February 21, 2025
Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia
Anna Maria Frustaci, Arianna Zappaterra, Andrea Galitzia, et al.
Hematological Oncology
|
May 29, 2023
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi
Maria E Nizzoli, Martina Manni, Chiara Ghiggi, et al.
Haematologica
|
April 7, 2018
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project
Barbara Mora, Toni Giorgino, Paola Guglielmelli, et al.
Haematologica
|
November 17, 2022
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)
Alessandra Tucci, Francesco Merli, Alberto Fabbri, et al.
Leukemia & Lymphoma
|
October 9, 2021
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi
Annalisa Arcari, Lucia Morello, Daniele Vallisa, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 117) with videos related to
Sort By:
Page
of 12
British Journal of Haematology
|
March 29, 2026
Hepatitis C virus and hepatitis B virus in indolent lymphomas: Prospective data from the international observational NF10 study
Luca Arcaini, Michele Merli, Sara Rattotti, et al.
Blood Cancer Journal
|
October 7, 2018
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project
Daniela Barraco, Barbara Mora, Paola Guglielmelli, et al.
Hematological Oncology
|
September 30, 2022
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi
Emanuele Cencini, Alessandra Tucci, Benedetta Puccini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2019
DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma
Ian W Flinn, Carole B Miller, Kirit M Ardeshna, et al.
Leukemia
|
December 15, 2019
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Marco Frigeni, Caroline Besson, Carlo Visco, et al.
Hemasphere
|
February 21, 2025
Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia
Anna Maria Frustaci, Arianna Zappaterra, Andrea Galitzia, et al.
Hematological Oncology
|
May 29, 2023
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi
Maria E Nizzoli, Martina Manni, Chiara Ghiggi, et al.
Haematologica
|
April 7, 2018
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project
Barbara Mora, Toni Giorgino, Paola Guglielmelli, et al.
Haematologica
|
November 17, 2022
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)
Alessandra Tucci, Francesco Merli, Alberto Fabbri, et al.
Leukemia & Lymphoma
|
October 9, 2021
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi
Annalisa Arcari, Lucia Morello, Daniele Vallisa, et al.
Page
of 12